Сорокин Максим Игоревич

Поиск прогностических, предиктивных и диагностических онкомаркеров с использованием ОМИКСных данных, в первую очередь результатах полноэкзомного профилирования и секвенирования РНК

1: Sorokin M, Zolotovskaia M, Nikitin D, Suntsova M, Poddubskaya E, Glusker A, Garazha A, Moisseev A, Li X, Sekacheva M, Naskhletashvili D, Seryakov A, Wang Y, Buzdin A. Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing data. BMC Cancer. 2022 Oct 31;22(1):1113. doi: 10.1186/s12885-022-10177-3. PMID: 36316649; PMCID: PMC9623986.
2: Rabushko E, Sorokin M, Suntsova M, Seryakov AP, Kuzmin DV, Poddubskaya E, Buzdin AA. Experimentally Deduced Criteria for Detection of Clinically Relevant Fusion 3' Oncogenes from FFPE Bulk RNA Sequencing Data. Biomedicines. 2022 Aug 2;10(8):1866. doi: 10.3390/biomedicines10081866. PMID: 36009413; PMCID: PMC9405289.
3: Zolotovskaia MA, Tkachev VS, Guryanova AA, Simonov AM, Raevskiy MM, Efimov VV, Wang Y, Sekacheva MI, Garazha AV, Borisov NM, Kuzmin DV, Sorokin MI, Buzdin AA. OncoboxPD: human 51 672 molecular pathways database with tools for activity calculating and visualization. Comput Struct Biotechnol J. 2022 May 10;20:2280-2291. doi: 10.1016/j.csbj.2022.05.006. PMID: 35615022; PMCID: PMC9120235.
4: Gudkov A, Shirokorad V, Kashintsev K, Sokov D, Nikitin D, Anisenko A, Borisov N, Sekacheva M, Gaifullin N, Garazha A, Suntsova M, Koroleva E, Buzdin A, Sorokin M. Gene Expression-Based Signature Can Predict Sorafenib Response in Kidney Cancer. Front Mol Biosci. 2022 Mar 14;9:753318. doi: 10.3389/fmolb.2022.753318. PMID: 35359606; PMCID: PMC8963850.
5: Sorokin M, Rabushko E, Efimov V, Poddubskaya E, Sekacheva M, Simonov A, Nikitin D, Drobyshev A, Suntsova M, Buzdin A. Experimental and Meta-Analytic Validation of RNA Sequencing Signatures for Predicting Status of Microsatellite Instability. Front Mol Biosci. 2021 Nov 23;8:737821. doi: 10.3389/fmolb.2021.737821. PMID: 34888350; PMCID: PMC8650122.
6: Sorokin M, Gorelyshev A, Efimov V, Zotova E, Zolotovskaia M, Rabushko E, Kuzmin D, Seryakov A, Kamashev D, Li X, Poddubskaya E, Suntsova M, Buzdin A. RNA Sequencing Data for FFPE Tumor Blocks Can Be Used for Robust Estimation of Tumor Mutation Burden in Individual Biosamples. Front Oncol. 2021 Sep 28;11:732644. doi: 10.3389/fonc.2021.732644. PMID: 34650919; PMCID: PMC8506044. 7: Seryakov A, Magomedova Z, Suntsova M, Prokofieva A, Rabushko E, Glusker A, Makovskaia L, Zolotovskaia M, Buzdin A, Sorokin M. RNA Sequencing for Personalized Treatment of Metastatic Leiomyosarcoma: Case Report. Front Oncol. 2021 Aug 30;11:666001. doi: 10.3389/fonc.2021.666001. PMID: 34527573; PMCID: PMC8435728.